FDS Amplicare Inc, a pharmacy software company, is awarding a USD25,000 grant to Community Pharmacy Enhanced Services Network (CPESN) Minnesota, it was reported on Wednesday.
The grant is to support independent pharmacies in preparing for opportunities to expand their provider offerings for Medicaid patients. The two-year program funded by the grant is intended to help up to 50 community pharmacies to receive implementation and training support to allow them to provide care under Medicaid CPT codes for Medication Therapy Management (MTM).
The MTM program is focused on management of chronic diseases such as diabetes and hypertension. If patients with chronic conditions can maintain their medication programs, unexpected hospital admissions and other unplanned health episodes can be reduced.
vTv Therapeutics secures USD51m private placement for cadisegliatin Phase 3 study
AbbVie names new chief executive officer
SkinBioTherapeutics expands foot care products in AMEA with Dermatonics partnership
Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment
Insulet's Omnipod 5 integration with Abbott FreeStyle Libre 2 Plus Sensor secures CE Mark approval
Kyowa Kirin enrols first subject in phase two tivozanib eye drops (KHK4951) clinical trial
China accepts GSK's Shingrix application for at-risk adults
Novo Nordisk to boost manufacturing capacity with acquisition of three fill-finish sites
Breye Therapeutics commences phase 1b/2a danegaptide clinical trial
DexCom Inc breaks ground on new manufacturing facility in Ireland
VibroSense Dynamics AB secures provisional patent for chemotherapy-induced nerve damage prediction
Innovent Biologics signs collaboration agreement with Sanegene Bio USA
Japan approves GSK's filing for Arexvy vaccination for at-risk adults